# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-060104
Filing Date
2025-04-29
Accepted
2025-04-29 16:07:46
Documents
19
Period of Report
2025-04-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | acet-20250429.htm iXBRL | DEF 14A | 1468166
2 | GRAPHIC | img106651080_0.jpg | GRAPHIC | 11570
3 | GRAPHIC | img106651080_1.jpg | GRAPHIC | 11570
4 | GRAPHIC | img106651080_2.jpg | GRAPHIC | 299210
5 | GRAPHIC | img106651080_3.jpg | GRAPHIC | 326308
6 | GRAPHIC | img106651080_4.jpg | GRAPHIC | 404005
7 | GRAPHIC | img106651080_5.jpg | GRAPHIC | 335285
| Complete submission text file | 0000950170-25-060104.txt |  | 6303033

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | acet-20250429.xsd | EX-101.SCH | 32701
21 | EXTRACTED XBRL INSTANCE DOCUMENT | acet-20250429_htm.xml | XML | 670184

Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38359 | Film No.: 25887415
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)